ICL eye surgery is a vision correction procedure where a small, prescription lens is permanently placed inside your eye, behind the iris and in front of your natural lens. Unlike LASIK, which reshapes your cornea with a laser, ICL adds a lens without removing any tissue. The procedure is FDA-approved for nearsightedness ranging from -3.0 to -20.0 diopters, making it one of the strongest options available for people with moderate to severe myopia.
How the Lens Works Inside Your Eye
ICL stands for Implantable Collamer Lens. The lens sits in a space called the ciliary sulcus, just behind the colored part of your eye (the iris) and just in front of your natural crystalline lens. It stays in this position permanently, correcting the way light focuses on your retina, much like a contact lens would, but from inside the eye.
The lens itself is made from Collamer, a flexible material that combines a synthetic polymer with a small amount of purified collagen. This blend gives the lens strong biocompatibility, meaning your eye tolerates it well with minimal inflammatory response after surgery. Collamer also has a lower refractive index than materials used in other implantable lenses, which helps reduce glare and light disturbances. The material contains a built-in UV filter, giving your eyes an added layer of protection from ultraviolet light.
The current version, called the EVO ICL, has a tiny 0.36 mm hole in its center called the KS-AquaPort. This port allows the fluid inside your eye (aqueous humor) to flow naturally through and around the lens. Older ICL models lacked this feature, which meant patients needed a separate laser procedure two to three weeks before surgery to create small holes in the iris to keep fluid circulating properly. The central port eliminated that extra step entirely.
Who Qualifies for ICL Surgery
The FDA approves the EVO ICL for patients between 21 and 45 years old. For myopia correction, it covers prescriptions from -3.0 diopters up to -15.0 diopters, with up to 2.5 diopters of astigmatism. For stronger prescriptions between -15.0 and -20.0 diopters, the lens can reduce nearsightedness rather than fully correct it. A separate version called the EVO TICL handles myopic astigmatism specifically, treating 1.0 to 4.0 diopters of cylinder.
One of ICL’s biggest advantages over laser procedures is that corneal thickness doesn’t matter. LASIK generally requires at least 520 microns of corneal tissue, and PRK can work with corneas as thin as 460 microns, because both procedures reshape the cornea itself. Since ICL doesn’t touch the cornea at all, thin corneas aren’t a disqualifying factor. This makes it a viable option for people who’ve been told their corneas are too thin for laser surgery.
Your prescription also needs to be stable, typically for at least a year before the procedure. People with certain conditions like glaucoma, cataracts, or inadequate space between the iris and natural lens may not be good candidates.
What the Procedure Is Like
ICL surgery is an outpatient procedure performed under local anesthesia, usually with numbing eye drops. The surgeon makes a small incision at the edge of the cornea, then inserts the folded Collamer lens through the opening. Once inside the eye, the lens unfolds and is positioned behind the iris. The incision is small enough that it typically self-seals without stitches.
The entire process is relatively quick. Each eye is usually done on a separate day, though some surgeons schedule both within a short window. Most patients notice improved vision almost immediately after the procedure, though it’s normal for things to look blurry or hazy at first.
Recovery Timeline
Recovery from ICL surgery is faster than many people expect. Most patients can see better right after the procedure, even though vision may be somewhat hazy in the first hours. Over the following days, clarity improves noticeably. The full healing period typically takes one to three months, during which your vision continues to sharpen and stabilize. You’ll have several follow-up appointments during this window so your surgeon can check the lens position and monitor eye pressure.
During the first week, you’ll likely need to avoid rubbing your eyes, swimming, and strenuous exercise. Eye drops to prevent infection and control inflammation are standard for the initial recovery period.
Risks and Complications
ICL surgery has a strong safety profile overall, but it carries risks that are worth understanding before you commit. The most significant long-term concern is cataract development. The rate of cataract formation within 10 years of ICL implantation is about 12.1%. The most common type is an anterior subcapsular cataract, which tends to develop on the front surface of your natural lens, right where the implanted lens sits closest. On average, these cataracts appear about three to four years after surgery when they do occur. If a cataract develops, it can be treated with standard cataract surgery, and the ICL is removed at the same time.
Elevated eye pressure is another concern, occurring in roughly 4.4% of patients after surgery. Secondary glaucoma, caused by pigment dispersion or fluid flow issues, occurs in 0 to 5% of cases. The timing varies, and some cases present early while others emerge months or years later. Regular follow-up appointments help catch pressure changes before they cause damage.
Because the lens sits inside the eye rather than on the cornea, there’s a small risk of infection (endophthalmitis) as with any intraocular procedure, though this is rare.
ICL vs. LASIK
The biggest practical difference is that ICL is additive and LASIK is subtractive. LASIK permanently removes corneal tissue to change its shape. ICL places a lens inside the eye without altering the cornea at all. This distinction matters for two reasons: ICL works regardless of corneal thickness, and it’s reversible. If your prescription changes significantly, or if a complication arises, the lens can be removed or replaced.
ICL also treats a wider range of nearsightedness. LASIK becomes less predictable and riskier at very high prescriptions, typically above -8.0 to -10.0 diopters depending on corneal thickness. ICL is FDA-approved up to -20.0 diopters. For mild to moderate prescriptions with adequate corneal thickness, LASIK remains a faster and less expensive option. ICL fills the gap for patients who fall outside LASIK’s safe parameters.
Cost and Insurance
ICL surgery is more expensive than LASIK. As of 2025, the typical cost ranges from $5,500 to $8,500 per eye, though prices vary by location and surgeon. Most insurance plans consider it an elective procedure and don’t cover it. Some practices offer financing plans or accept health savings account (HSA) and flexible spending account (FSA) funds to help spread out the cost.
The higher price reflects the cost of the custom-manufactured lens itself, which is sized and powered specifically for each patient’s eye. Unlike LASIK, which uses a laser already owned by the practice, every ICL procedure requires ordering a unique implant.